Cargando…
The Heart of the Problem in Multisystem Inflammatory Syndrome in Children
Multisystem inflammatory syndrome in children (MIS-C) is a severe, life-threatening, post-COVID-19 hyperinflammatory illness that is not yet fully understood. In this issue of Med, de Cevins et al. used a multi-parametric approach to define COVID-19-related disease, specifically identifying a molecu...
Autores principales: | Boribong, Brittany P., Arya, Puneeta, Yonker, Lael M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431922/ https://www.ncbi.nlm.nih.gov/pubmed/34522906 http://dx.doi.org/10.1016/j.medj.2021.08.008 |
Ejemplares similares
-
Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022) -
Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022) -
299. Systems immunology profiling of treatment-naïve children with multisystem inflammatory syndrome
por: Zheng, Hong, et al.
Publicado: (2022) -
Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
por: Yonker, Lael M., et al.
Publicado: (2022) -
Long-term humoral signatures following acute pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
por: Burns, Madeleine D., et al.
Publicado: (2023)